Irinozee 40mg (Irinotecan Vials) 40mg/5ml

Irinozee 40mg is a chemotherapy medication containing irinotecan, used to treat various cancers. This 40mg/5ml vial form is designed for intravenous administration. Store between 15-25°C. Always follow healthcare provider guidance when using this prescription medication.

Strength

40mg/5ml

Pack Size

Storage

15-25°

Manufacturer / TM Owner

zee lab

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Irinotecan, the active ingredient in Irinozee 40mg, is commonly used to treat colorectal cancer and other solid tumors. It belongs to the topoisomerase I inhibitor class of chemotherapy drugs. Patients often ask what is irinotecan used for, as it may be prescribed for conditions beyond colorectal cancer. The medication works by interfering with cancer cell growth.

Side Effects

Common effects of irinotecan therapy may include gastrointestinal symptoms like nausea or diarrhea. Some patients report fatigue or changes in blood cell counts during treatment. These effects vary by individual and treatment protocol. Always discuss any concerns with your healthcare provider.

Precautions & Warnings

Handle Irinozee 40mg vials with care, using proper medical protocols for chemotherapy agents. Avoid contact with skin or mucous membranes during preparation and administration. Use protective equipment as recommended. Keep vials in original packaging until ready for use.

Avoid Interactions

Irinotecan may interact with other medications, including certain anticonvulsants or CYP3A4 inhibitors. Alcohol consumption during treatment may increase side effects. Always inform your healthcare provider about all medications you're taking. Some herbal supplements may also interact with irinotecan therapy.

Frequently Asked Questions

Irinotecan is primarily used to treat colorectal cancer and other solid tumors as part of chemotherapy regimens.

This medication is given by intravenous infusion, typically in a clinical setting under medical supervision.

Common effects may include nausea, diarrhea, fatigue, or changes in blood cell counts during treatment.

Prescription chemotherapy medications like Irinozee 40mg require proper medical authorization for purchase.

Store vials between 15-25°C in original packaging until ready for use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.